EZH2 inhibitors in immunotherapy of melanoma

被引：1
|
作者：
Hersey, Peter
Gallagher, Stuart
Tiffen, Jessamy
Shklovskaya, Elena
Wilson, Stephen
Filipp, Fabian
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
基金：
美国国家卫生研究院; 澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
10.1158/1538-7445.AM2017-1676
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1676
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Small molecule inhibitors of EZH2: the emerging translational landscape
    Keilhack, Heike
    Smith, Jesse J.
    EPIGENOMICS, 2015, 7 (03) : 337 - 341
  • [42] Integrated analyses of prognostic and immunotherapeutic significance of EZH2 in uveal melanoma
    Li, Junfang
    Zhang, Yifei
    Yang, Qiu
    Qu, Yi
    METHODS, 2025, 234 : 242 - 252
  • [43] EZH2: an emerging role in melanoma biology and strategies for targeted therapy
    Tiffen, Jessamy
    Gallagher, Stuart J.
    Hersey, Peter
    PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (01) : 21 - 30
  • [44] EZH2 copy number gain as a therapeutic target in mucosal melanoma
    Yu, Huan
    Kong, Yan
    Yan, Junya
    Ma, Meng
    Xu, Longwen
    Yu, Jiayi
    Xu, Tianxiao
    Dai, Jie
    Tang, Huan
    Wu, Xiaowen
    Chi, Zhihong
    Si, Lu
    Shen, Xinan
    Tang, Bixia
    Lian, Bin
    Wang, Xuan
    Li, Siming
    Bai, Xue
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target
    Cao, Jinfeng
    Pontes, Kelly C. S.
    Heijkants, Renier C.
    Brouwer, Niels J.
    Groenewoud, Arwin
    Jordanova, Ekaterina S.
    Marinkovic, Marina
    van Duinen, Sjoerd
    Teunisse, Amina F. A. S.
    Verdijk, Robert M.
    Snaar-Jagalska, Ewa
    Jochemsen, Aart G.
    Jager, Martine J.
    JOURNAL OF PATHOLOGY, 2018, 245 (04): : 433 - 444
  • [46] Epigenetics Markers in Acral Lentiginous/Mucosal Melanoma: Expression of EZH2
    Li-Ning-Tapia, E. M.
    Curry, J.
    Zhang, P.
    Prieto, V. G.
    Torres-Cabala, C. A.
    LABORATORY INVESTIGATION, 2011, 91 : 119A - 120A
  • [47] Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma
    Al Emran, Abdullah
    Fisher, David E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (04) : 1004 - 1006
  • [48] Epigenetics Markers in Acral Lentiginous/Mucosal Melanoma: Expression of EZH2
    Li-Ning-Tapia, E. M.
    Curry, J.
    Zhang, P.
    Prieto, V. G.
    Torres-Cabala, C. A.
    MODERN PATHOLOGY, 2011, 24 : 119A - 120A
  • [49] EZH2 Inactivates Primary Cilia to Activate Wnt and Drive Melanoma
    Jackson, Peter K.
    CANCER CELL, 2018, 34 (01) : 3 - 5
  • [50] Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas
    Lue, Jennifer K.
    Prabhu, Sathyen A.
    Liu, Yuxuan
    Gonzalez, Yulissa
    Verma, Akanksha
    Mundi, Prabhjot S.
    Abshiru, Nebiyu
    Camarillo, JeannieM.
    Mehta, Swasti
    Chen, Emily I.
    Qiao, Changhong
    Nandakumar, Renu
    Cremers, Serge
    Kelleher, Neil L.
    Elemento, Olivier
    Amengual, Jennifer E.
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5271 - 5283
12345